-
High-Dose Rofecoxib Confirmed Prothrombotic, Study Shows; Losartan Better Than Atenolol for LVH Treatment; Lisinopril, Not Losartan, Improves Myocardial Perfusion; New Fluoroquinolone Study; Warfarin After MI Better Than Aspirin Alone; FDA News
-
In this feature, brief items, primarily gleaned from abstracts or articles in journals and other resources not commonly perused by most US
infectious disease physicians, will be presented, usually without comment.
-
Passage through the human gastrointestinal tract enhances the infectiousness of Vibrio cholerae.
-
-
The CDC has published a new set of recommendations aimed at preventing health care-associated infections by optimizing hand hygiene in health care personnel. The following is a summary of some of those recommendations, selected because of their strength and/or novelty.
-
The excess risk of Achilles tendon disorders attributable to fluoroquinolone use was estimated to be 3.2 cases per 1000 patient-years, with most of that increase accounted for by patients 60 years of age and older who concomitantly receive corticosteroids.
-
In this feature, brief items, primarily gleaned from abstracts or articles in journals and other resources not commonly perused by most US infectious disease physicians, will be presented, usually without comment.
-
The proposal for the study, A Multicenter, Randomized Dose Response Study of the Safety, Clinical and Immune Responses of DryVax Vaccine Administered to Children 2 to 5 Years of Age, provides the following details.
-
The 10-page human subjects consent form proposed for the Dryvax vaccination study of children, ages 2 to 5, has a number of flaws, according to the IRBs and experts who have reviewed the study proposal and consent form.
-
Once a final decision is made regarding some proposed research involving very young children and an older smallpox vaccine, there could be long-term repercussions for IRBs nationwide.